Compositions and methods for the treatment of inflammation and lipid disorders

作者: Mahesh Kandula

DOI:

关键词:

摘要: The compounds of formula I and II or its pharmaceutical acceptable salts, as well polymorphs, solvates, enantiomers, stereoisomers hydrates thereof are disclosed. compositions comprising an effective amount may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, injection. Such used to treatment hypertriglyceridemia, steatohepatitis, cystinosis inflammatory diseases.

参考文章(149)
Thomas Raymond Herrin, Charles Arthur Flentge, Phenobarbital and carbamazepine enzyme inhibitors ,(1984)
Lluis Sola Carandell, Jordi Benet-Buchholz, Francisco Eugenio Palomo Nicolau, Andrés Molina Ponce, Process for preparing entacapone substantially free of z-isomer, synthesis intermediates thereof and a new crystalline form ,(2008)
Robert J. Carrico, Robert C. Boguslaski, John F. Burd, Beta-galactosyl-umbelliferone-labeled hapten conjugates ,(1981)
Vishal Pendharker, Yu Chen, Michael Foley, Geeta Sharma, Ralf Altmeyer, Compositions and methods for treating viral infections ,(2009)
Prasad Raje, Jian-Xie Chen, John M. McCall, Rajendrakumar Ruddy Gadikota, Olga V. Lapina, Synthesis of chirally purified substituted benzothiazoles ,(2008)
Peter M. Smith-Jones, Hanwen Zhang, Sean D. Carlin, Compounds useful as carbonic anhydrase modulators and uses thereof ,(2010)
Peter A. Virsik, Daniel M. Canafax, Joseph C. Benson, Use of Prodrugs of GABA B Agonists for Treating Neuropathic and Musculoskeletal Pain ,(2008)